SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Dixie7777 who wrote (3824)8/26/1998 6:42:00 PM
From: Jim B  Read Replies (1) | Respond to of 5402
 
well, let's see what the new IR firm can do to help rally the troops..

I would like to know how many shares was paid to the new IR firm and
whether it is done monthly or they got a lump sum up front for a
certain amount of time or whether they paid for it with some of the
financing they've gotten..

jim



To: Dixie7777 who wrote (3824)8/29/1998 7:42:00 PM
From: drdan  Read Replies (1) | Respond to of 5402
 
Hey, everyone....I don't want to be negative or anything but the bottom line here with pr is that investors, especially institutions, want to see some data suggesting efficacy of the product before they plunk down major dollars on Sanguine....you could explain the product to the public until you are blue in the face but until there is hard data, most people will say"that's nice" and move on.....but it never hurts to spread the word, anyway.Hope that everyone's doing well.